CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-06 | Pittman Scott M. Director | Grant or award · Second Restated Warrant (right to buy) | +4,500 | $1.50 | $7K | 4,500 |
| 2026-10-06 | Pittman Scott M. Director | Grant or award · Prepayment Restated Warrant (right to buy) | +458 | $1.50 | $687 | 458 |
| 2026-08-28 | JORDEN DAVID EMERSON CEO/CFO | Purchase | +7,984 | $1.09 | $9K | 2,070,000 |
| 2026-08-28 | JORDEN DAVID EMERSON CEO/CFO | Grant or award | +7,984 | $1.09 | $9K | 2,070,000 |
| 2026-08-27 | JORDEN DAVID EMERSON CEO/CFO | Purchase | +789 | $1.07 | $844 | 2,062,016 |
| 2026-08-27 | JORDEN DAVID EMERSON CEO/CFO | Grant or award | +789 | $1.07 | $844 | 2,062,016 |
| 2026-06-30 | JORDEN DAVID EMERSON CEO/CFO | Option exercise | +162,500 | $1.00 | $163K | 2,222,119 |
| 2026-06-30 | JORDEN DAVID EMERSON CEO/CFO | Shares withheld for taxes | −160,892 | $1.01 | $163K | 2,061,227 |
| 2026-06-30 | JORDEN DAVID EMERSON CEO/CFO | Option exercise · Option to purchase common stock | −162,500 | 0 | ||
| 2026-06-30 | Pittman Scott M. Director | Option exercise | +40,000 | $1.00 | $40K | 5,440,000 |
| 2026-06-30 | Pittman Scott M. Director | Shares withheld for taxes | −39,604 | $1.01 | $40K | 5,400,396 |
| 2026-06-30 | Pittman Scott M. Director | Option exercise · Option to purchase common stock | −40,000 | 0 | ||
| 2026-06-30 | WINZER C ERIC Director | Option exercise | +40,000 | $1.00 | $40K | 212,654 |
| 2026-06-30 | WINZER C ERIC Director | Shares withheld for taxes | −39,604 | $1.01 | $40K | 173,050 |
| 2026-06-30 | WINZER C ERIC Director | Option exercise · Option to purchase common stock | −40,000 | 0 | ||
| 2026-06-29 | CLAUSEN PETER CSO/COO | Grant or award · Option to purchase common stock | +65,000 | 65,000 | ||
| 2026-06-29 | JORDEN DAVID EMERSON CEO/CFO | Grant or award · Option to purchase common stock | +125,000 | 125,000 | ||
| 2026-06-29 | Pittman Scott M. Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2026-06-29 | WINZER C ERIC Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2026-06-29 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +30,000 | 30,000 |
Page 1 of 17 · 326 trades